James W. Green
Net Worth

Last updated:

What is James W. Green net worth?

The estimated net worth of Mr. James W. Green is at least $9,078,506 as of 13 Jun 2024. He owns shares worth $1,524,435 as insider, has earned $970,311 from insider trading and has received compensation worth at least $6,583,760 in Harvard Bioscience, Inc..

What is the salary of James W. Green?

Mr. James W. Green salary is $822,970 per year as Pres, Chief Executive Officer & Chairman in Harvard Bioscience, Inc..

How old is James W. Green?

Mr. James W. Green is 67 years old, born in 1958.

What stocks does James W. Green currently own?

As insider, Mr. James W. Green owns shares in one company:

Company Title Shares Price per share Total value
Harvard Bioscience, Inc. (HBIO) Pres, Chief Executive Officer & Chairman 3,111,091 $0.49 $1,524,435

What does Harvard Bioscience, Inc. do?

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.

James W. Green insider trading

Harvard Bioscience, Inc.

Mr. James W. Green has made 6 insider trades between 2017-2024, according to the Form 4 filled with the SEC. Most recently he purchased 10,000 units of HBIO stock worth $29,100 on 13 Jun 2024.

The largest trade he's ever made was exercising 48,175 units of HBIO stock on 23 Aug 2021. As of 13 Jun 2024 he still owns at least 3,111,091 units of HBIO stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 10,000 $2.91 $29,100
Purchase
Common Stock 20,000 $3.07 $61,400
Purchase
Common Stock 25,000 $4.38 $109,500
Purchase
Common Stock 20,000 $2.6 $52,000
Purchase
Common Stock 20,000 $2.67 $53,400
Purchase
Common Stock 15,000 $2.61 $39,150
Purchase
Common Stock 15,000 $2.41 $36,150
Purchase
Common Stock 40,000 $3.19 $127,600
Purchase
Common Stock 30,000 $3.71 $111,300
Purchase
Common Stock 10,000 $3.4 $34,000
Purchase
Common Stock 30,000 $3.78 $113,400
Sale
Common Stock 48,175 $8.02 $386,364
Option
Stock option (right to buy) 24,312 $2.63 $63,941
Option
Common Stock 24,312 $2.63 $63,941
Sale
Common Stock 24,312 $2.63 $63,941
Sale
Common Stock 14,876 $7.03 $104,578
Option
Stock option (right to buy) 14,876 $7.03 $104,578
Option
Common Stock 14,876 $7.03 $104,578
Option
Common Stock 39,188 $2.63 $103,064
Sale
Common Stock 39,188 $2.63 $103,064
Option
Stock option (right to buy) 39,188 $2.63 $103,064
Option
Common Stock 39,188 $2.63 $103,064
Option
Stock option (right to buy) 39,188 $2.63 $103,064
Sale
Common Stock 39,188 $2.63 $103,064
Sale
Common Stock 35,000 $5.98 $209,300
Purchase
Common Stock 10,000 $2.53 $25,300
Purchase
Common Stock 10,000 $2.61 $26,100
Purchase
Common Stock 10,000 $2.49 $24,850
Purchase
Common Stock 20,000 $2.47 $49,320
Purchase
Common Stock 5,000 $5.74 $28,700
Purchase
Common Stock 7,712 $2.55 $19,666

Harvard Bioscience key executives

Harvard Bioscience, Inc. executives and other stock owners filed with the SEC: